These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33914971)

  • 21. Cochrane Review: Screening programmes for developmental dysplasia of the hip in newborn infants.
    Shorter D; Hong T; Osborn DA
    Evid Based Child Health; 2013 Jan; 8(1):11-54. PubMed ID: 23878122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of Pubofemoral Distance in the Diagnosis of Developmental Dysplasia of the Hip: Sensitivity and Specificity.
    Motta GGB; Chiovatto ARS; Chiovatto ED; Duarte ML; de Lourenço AF; Takahashi MS; Rodrigues NVM; Iared W
    J Ultrasound Med; 2022 May; 41(5):1205-1212. PubMed ID: 34405425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for developmental dysplasia of the hip: results of a 7-year follow-up study.
    Sahin F; Aktürk A; Beyazova U; Cakir B; Boyunaga O; Tezcan S; Bölükbaşi S; Kanatli U
    Pediatr Int; 2004 Apr; 46(2):162-6. PubMed ID: 15056242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of early developmental dysplasia of the hip in universal ultrasonographic screening of newborns: analysis and evaluation of risk factors.
    Kolb A; Schweiger N; Mailath-Pokorny M; Kaider A; Hobusch G; Chiari C; Windhager R
    Int Orthop; 2016 Jan; 40(1):123-7. PubMed ID: 25940606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of selective ultrasound screening on late presenting DDH.
    Zenios M; Wilson B; Galasko CS
    J Pediatr Orthop B; 2000 Oct; 9(4):244-7. PubMed ID: 11143466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of orthopedic and sonographic hip examinations in the first days after birth based on research conducted in neonatal units and outpatient clinics].
    Rydzak B; Snela S; Bielak R; Naszkiewicz B; Bilski P
    Chir Narzadow Ruchu Ortop Pol; 2004; 69(2):105-7. PubMed ID: 15307381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Z-score to optimize population-specific DDH screening: a retrospective study in Hangzhou, China.
    Li H; Shu L; Yu J; Xian Z; Duan H; Shu Q; Ye J
    BMC Musculoskelet Disord; 2021 Apr; 22(1):344. PubMed ID: 33845817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association of Asymmetric Skinfolds and the Diagnosis of Developmental Dysplasia of the Hip in Infants.
    Liu B; Hu X; Li L; Gao S
    Adv Neonatal Care; 2022 Aug; 22(4):352-356. PubMed ID: 34387217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of primary care 6- to 8-week hip check for diagnosis of developmental dysplasia of the hip: a 15-year observational cohort study.
    Davies R; Talbot C; Paton R
    Br J Gen Pract; 2020 Apr; 70(693):e230-e235. PubMed ID: 32094221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening of dysplasia of the hip in Denmark].
    Husum HC; Møller-Madsen B; Thomsen JL; Maimburg RD; Rahbek O
    Ugeskr Laeger; 2021 Mar; 183(12):. PubMed ID: 33829997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of screening for developmental dysplasia of the hip in the Liberec region in 1984-2005].
    Vencálková S; Janata J
    Acta Chir Orthop Traumatol Cech; 2009 Jun; 76(3):218-24. PubMed ID: 19595284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The positive predictive value of asymmetrical skin creases in the diagnosis of pathological developmental dysplasia of the hip.
    Anderton MJ; Hastie GR; Paton RW
    Bone Joint J; 2018 May; 100-B(5):675-679. PubMed ID: 29701087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in Australian screening guidelines for developmental dysplasia of the hip.
    Marriott E; Twomey S; Lee M; Williams N
    J Paediatr Child Health; 2021 Dec; 57(12):1857-1865. PubMed ID: 34555227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tübingen hip flexion splints for developmental dysplasia of the hip in infants aged 0-6 months.
    Zhou Y; Li R; Li C; Zhou P; Li Y; Ke YH; Jiang F; Kang XP
    BMC Pediatr; 2020 Jun; 20(1):280. PubMed ID: 32503452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine ultrasound screening for hip dysplasia in children with clubfoot is not supported.
    McLaughlin D; De Salvo S; Brewerton K; Hui C; Bouchard M
    Int Orthop; 2024 Jul; 48(7):1793-1797. PubMed ID: 38602555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of selective ultrasound screening on the incidence of late presentation of developmental hip dysplasia-a meta-analysis.
    Laborie LB; Rosendahl K; Dhouib A; Simoni P; Tomà P; Offiah AC
    Pediatr Radiol; 2023 Sep; 53(10):1977-1988. PubMed ID: 37099154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of abduction treatment in developmental dysplasia of the hip. Analysis of 900 patients.
    Lankinen V; Vuorinen RL; Helminen M; Bakti K; Välipakka J; Laivuori H; Hyvärinen A
    Ann Med; 2023; 55(2):2290694. PubMed ID: 38065688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Initial results from an ultrasound screening program for the detection of developmental dysplasia of the hip in girls].
    Salut C; Moriau D; Pascaud E; Layré B; Peyrou P; Maubon A
    J Radiol; 2011 Oct; 92(10):920-9. PubMed ID: 22000614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of selected risk factors in developmental dysplasia of the hip: an observational study.
    Talbot CL; Paton RW
    Arch Dis Child; 2013 Sep; 98(9):692-6. PubMed ID: 23852998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal screening for developmental dysplasia of the hip on the maternity wards in Crete, Greece. correlation to risk factors.
    Giannakopoulou C; Aligizakis A; Korakaki E; Velivasakis E; Hatzidaki E; Manoura A; Bakataki A; Hadjipavlou A
    Clin Exp Obstet Gynecol; 2002; 29(2):148-52. PubMed ID: 12171320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.